{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9"}],"title":"Substudy 1"},{"measurements":[{"groupId":"OG000","value":"25"}],"title":"Substudy 2"},{"measurements":[{"groupId":"OG000","value":"106"}],"title":"Substudy 3"},{"measurements":[{"groupId":"OG000","value":"4"}],"title":"Substudy 4"},{"measurements":[{"groupId":"OG000","value":"30"}],"title":"Substudy 5"},{"measurements":[{"groupId":"OG000","value":"20"}],"title":"Substudy 6"},{"measurements":[{"groupId":"OG000","value":"14"}],"title":"Substudy 7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"208"}],"units":"Participants"}],"description":"Number of Participants who passed screening and were randomized across sub studies are presented.","groups":[{"description":"Participants with Relapsed/Refractory Multiple Myeloma (RRMM) were screened to be randomized in sub-studies of this master protocol.","id":"OG000","title":"All Screened Participants"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All participants who passed screening and were randomized.","reportingStatus":"POSTED","timeFrame":"Day 1","title":"Number of Participants Randomized Across Sub-studies","type":"PRIMARY","unitOfMeasure":"Participants"}